Traumatic Brain Injury (TBI)

HBOT is the only therapy that directly treats the underlying disease processes of TBI (decreased oxygen, decreased blood flow, swelling of the brain, constriction of blood vessels, acidosis, anaerobic metabolism). HBOT has been shown in multiple studies to have the greatest reduction in mortality of any therapy. One to three sessions of HBOT in the acute period can decrease the mortality by 50-60% (Rockswold review). (Dr. Harch’s study in veterans with blast TBI and PTSD. The discussion section includes a review of all of the HBOT studies in mild TBI persistent post-concussion syndrome).